The Chicago Bears are going to need to fix their entire defensive line. They will need a couple of defensive tackles and may acquire players through the draft and free agency. One name to keep an eye on is A'Shawn Robinson.
Should Chicago Bears sign A'Shawn Robinson in free agency?
According to Spotrac, he is projected to get about $8M per year, but according to PFF that number $2.5. This will be a fun one to follow, but he may end up closer to the PFF number.
The big reason is that he tore his meniscus in November. He may be getting going in training camp, but you cannot expect him to be back to himself for most of this season. Still, what the Chicago Bears could be doing is buying low on a player with some upside, and then hoping that there is a big payoff.
Robinson has been in the NFL for seven seasons, going on eight. Still, he will be 28 years old next season. There are still a few good seasons in him, even if the next season is a bit up and down do his recovery.
When he is healthy, A'Shawn Robinson is a trusted run defender. That is exactly what the Chicago Bears need to find. What is nice about Robinson is that he is used to playing the 1-technique role, which means he would be next to the bigger pass rusher. You saw that on the Rams when Aaron Donald would be the pass rushing 3-technique, and Robinson would be the 1-technique next to him.
The Chicago Bears would love to find a cheap, but efficient run defender. That would allow them to go big on the 3-technique next to him. Whether it be DeForest Buckner, Javon Hargrave, or Jalen Carter, the Bears have options to fix that hole.
If they pair any of those big names with A'Shawn Robinson it could become a real long-term fit. The talent of those names would take pressure off of Robinson early into his time back on the field, and then when he gets healthy, the duo could become one of the best.
When it comes to A'Shawn Robinson and his free agency, the price tag will be everything. The Chicago Bears should listen to PFF, and if that is his market, they could be in the mix. If the market is closer to what Spotrac is suggesting, that is a lot of risk for the injury and the timing of the injury.